Article

Breast cancer ovarian metastases show increased activity of GPCR pathways

2026-07-31

Abstract excerpt

Treatment resistance and metastases occur in 10–20% of patients with invasive lobular carcinoma (ILC), the most common special histological subtype of breast cancer. ILC metastasizes to the ovary more frequently than no special type (NST) tumors, also known as invasive ductal carcinoma (IDC). To characterize the genomic landscape of breast cancer ovarian metastases, we analyzed 15,613 local breast cancers, 22,010...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3be40fc4-256a-57ee-a668-a658b1143b39
DOI: 10.64898/2026.07.30.741805

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Breast cancer ovarian metastases show increased activity of GPCR pathwaysDOI 10.64898/2026.07.30.741805Read

Genomic landscape of metastatic breast cancer identifies preferentially dysregulated pathways and targets.Semantic proximity Read

The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors.Semantic proximity Read

Molecular Concordance Between Primary Breast Cancer and Matched MetastasesSemantic proximity Read

Multiplatform Analysis of Primary and Metastatic Breast Tumors from the AURORA US Network identifies microenvironment and epigenetics drivers of metastasisSemantic proximity Read

Beyond Genetics: Metastasis as an Adaptive Response in Breast CancerSemantic proximity Read

Upregulation of <i>GREB1</i> in colorectal cancer ovarian metastases may be a potential therapeutic targetSemantic proximity Read

Integrated Genomic and Epigenomic Analysis of Breast Cancer Brain MetastasisSemantic proximity Read

Liver tropism of ER mutant breast cancer is characterized by unique molecular changes and immune infiltration.Semantic proximity Read

Mutation characteristics and molecular evolution of ovarian metastasis from gastric cancer and potential biomarkers for paclitaxel treatment.Semantic proximity Read

Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.Semantic proximity Read

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasisSemantic proximity Read

Genetic alterations and their association with clinicopathologic characteristics in advanced breast carcinomas: focusing on clinically actionable genetic alterations.Semantic proximity Read